作者
Biao Huang,Zipeng Zeng,Hui Li,Zexu Li,Xi Chen,Jinjin Guo,Chennan Zhang,Megan E. Schreiber,Ariel C. Vonk,Tianyuan Xiang,Tadrushi Patel,Yidan Li,Riana K. Parvez,Bálint Dér,J. Chen,Zhenqing Liu,Matthew E. Thornton,Brendan H. Grubbs,Yarui Diao,Yali Dou,Ksenia Gnedeva,Nils O. Lindström,Qi‐Long Ying,Núria M. Pastor‐Soler,Fei Teng,Kenneth R. Hallows,Andrew P. McMahon,Zhongwei Li
摘要
Nephron progenitor cells (NPCs) self-renew and differentiate into nephrons, the functional units of the kidney. Here we report manipulation of p38 and YAP activity creates a synthetic niche that allows the long-term clonal expansion of primary mouse and human NPCs, and induced NPCs (iNPCs) from human pluripotent stem cells. Cultured iNPCs resemble closely primary human NPCs, generating nephron organoids with abundant distal convoluted tubule cells, which are not observed in published kidney organoids. The synthetic niche reprograms differentiated nephron cells into NPC state, recapitulating the plasticity of developing nephron in vivo. Scalability and ease of genome-editing in the cultured NPCs allow for genome-wide CRISPR screening, identifying novel genes associated with kidney development and disease. A rapid, efficient, and scalable organoid model for polycystic kidney disease was derived directly from genome-edited NPCs, and validated in drug screen. These technological platforms have broad applications to kidney development, disease, plasticity, and regeneration.